This inventor holds 2 USPTO granted patents. Top assignee: Becton Dickinson and Company Limited. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Christine Ann Rostkowski: Innovator in Mycobacterium Detection
Introduction
Christine Ann Rostkowski is a notable inventor based in Baltimore, MD, recognized for her contributions to the field of biotechnology. With a focus on mycobacterial detection, she holds two patents that highlight her innovative methods for amplifying and detecting specific genes related to the Mycobacterium avium Complex (MAC).
Latest Patents
Christine’s latest patents are groundbreaking in the realm of molecular biology. The first patent pertains to the amplification and detection of the alpha antigen gene of mycobacterium. This invention provides oligonucleotide primers derived from the BCG-85B gene of mycobacteria, along with methods for complex-specific amplification of a fragment of this gene. Additionally, it includes a detector probe for effectively identifying the amplification products in MAC species.
The second patent addresses the amplification and detection of various mycobacterium avium complex species. It introduces amplification primers and methods for complex-specific amplification of target sequences located in the dnaJ genes of MAC species. Her innovation facilitates the identification of MAC species and supports multiplex amplification reactions, enhancing detection capabilities.
Career Highlights
Christine Ann Rostkowski is currently employed at Becton Dickinson and Company Limited, where she continues to make significant strides in her field. Her career is marked by a commitment to enhancing diagnostic methods and improving public health outcomes through innovative technologies.
Collaborations
Throughout her career, Christine has collaborated with talented colleagues, including Silvia A. Bustos and Keith C. Williams, contributing to a rich environment of shared knowledge and expertise within her field. These partnerships have undoubtedly propelled her work forward, fostering advancements in mycobacterial research.
Conclusion
Christine Ann Rostkowski exemplifies the spirit of innovation in the biotechnology sector, with her patents serving as vital tools for the detection of mycobacterium species. Her contributions not only reflect her expertise but also the collaborative efforts that drive scientific progress. As her career progresses, she continues to pave the way for future advancements in medical diagnostics.